Cellectis to Participate in Upcoming Investor Conferences

Published on September 02, 2020 in New York, NY

Back to all press releases

September 1st, 2020 – New York (N.Y.) Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), will present at several upcoming investor conferences. Webcast information when available will be posted in the Investor Relations section of the Company’s website at https://www.cellectis.com/en/investors/events-and-webcasts/.

Citi Annual BioPharma Conference September 9, 2020 from 3:20 PM to 4:05 PM EDT

André Choulika, Chairman & CEO, to participate in a panel on Innovation in Cell Therapy.

Wells Fargo Healthcare Conference Boston September 10, 2020 from 8:00 AM to 8:30 AM EDT

André Choulika; Carrie Brownstein, CMO; Simon Harnest, VP, Corporate Strategy & Finance to provide a company presentation.

Baird’s 2020 Global Healthcare Conference September 10, 2020 at 3:10 PM EDT

Simon Harnest to participate in a firechat and a live Q&A.

Bank of America Healthcare Conference London September 17, 2020 from 4:55 AM to 5:45 AM EDT

André Choulika to provide a company presentation.

Download the PDF file